Cite
Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
MLA
Keiichiro Mori, et al. “Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser’s Letter to the Editor Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et Al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Eur Urol. In Press. Https://Doi.Org/10.1016/j.Eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?” European Urology, vol. 79, no. 4, Dec. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cbd200a510b8931b516707679eeffd4b&authtype=sso&custid=ns315887.
APA
Keiichiro Mori, Manuela Schmidinger, Shin Egawa, Kilian M. Gust, & Shahrokh F. Shariat. (2020). Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser’s Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer? European Urology, 79(4).
Chicago
Keiichiro Mori, Manuela Schmidinger, Shin Egawa, Kilian M. Gust, and Shahrokh F. Shariat. 2020. “Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser’s Letter to the Editor Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et Al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Eur Urol. In Press. Https://Doi.Org/10.1016/j.Eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?” European Urology 79 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cbd200a510b8931b516707679eeffd4b&authtype=sso&custid=ns315887.